cost of noom glp 1 Program in 2026: Explore Pricing & Benefits noomhealth #employerbenefits #glp1 #noomsmart #hlth
Description
2023 Nov 3:1-8 Yin J, Xing H, Ye J
Descriptive and systematic reviews helped to build the discussion section
Available from: Deanfield J, Verma S, Scirica BM, Kahn SE, Emerson SS, Ryan D et al (2024) Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial
Major Findings: Produced significant dose-dependent reductions in HbA1c
And some people have dropped out of studies because they feel theyre losing too much weight
